ELMWOOD PARK, N.J., Aug. 21, 2017 /PRNewswire/ -- BioReference Laboratories, one of the nation's largest, full-service clinical diagnostic laboratories, today formally announced the appointment of Victoria L. Laughman as Executive Vice President of Sales. With more than two decades of industry experience, including a stint at BioReference's GeneDx genetics division, Ms. Laughman will lead a national sales force from BioReference's corporate headquarters in Elmwood Park, NJ.
Prior to her new post, Ms. Laughman previously served as director of physician outreach and development for the John Muir Health System in California; she was also the president and co-founder of Caretinuum LLC, a Dallas-based firm that marketed hospital laboratory services to local physicians. At all levels, Ms. Laughman worked closely with her colleagues to ensure adherence to exacting strictures set forth by both institutional and corporate compliance departments -- standards she will enforce in her new role at BioReference.
"We are pleased to have a professional of Vicki's caliber and leadership qualities join our team," said Gregory Henderson, MD, PhD, President of BioReference Laboratories. "From pharmacy benefit managers (PBMs) to lab services to health systems, Vicki has led both startups and established institutions towards exponential growth and sustained success. We look forward to her doing the same with our team here at BioReference."
As EVP of sales, Ms. Laughman will lead a national sales force of more than 400, providing physician clients, hospitals and health systems a one-stop shop for services from routine testing to highly-specialized esoteric assays.
"Today, 'value-based care' is more than a buzzword – at BioReference, it's a guiding philosophy," says Ms. Laughman. "To that end, we work to get our clients not just the testing services their patients need, but the accurate, quick-turnaround results they expect. We recognize the critical role that laboratory diagnostics plays in today's value-based environment, and for providers, there is no better collaborator in care than BioReference."
She joins BioReference at a time when the company is going through a transformative period in its 30-year history, with a renewed focus on areas such as utilization management and corporate compliance. Ms. Laughman will work closely with BioReference's executive leadership, legal, and compliance teams on implementing more formal sell programs, as well as policy and skill development.
"BioReference is an excellent company, but in this time of healthcare transformation every organization should strive to change for the better," said Ms. Laughman. "I am thrilled and honored to be part of this organization, and look forward to helping take it to the next level."
About BioReference Laboratories, Inc.
BioReference Laboratories is one of the largest and fastest growing full-service diagnostic laboratories in the world, providing clinical testing services to physician offices, clinics, hospitals, long-term care facilities and employers while also advancing drug discovery and development with disease foundations, academic and pharmaceutical partners. BioReference's comprehensive testing capabilities and expertise spans molecular diagnostics, anatomical pathology, women's health, oncology and rare disease genetics. For more information, visit www.bioreference.com.
SOURCE BioReference Laboratories, Inc.